Bio-misc
(Die Seite wurde neu angelegt: „{{tp|p=32398026|t=2020. Allo-priming as a universal anti-viral vaccine: protecting elderly from current COVID-19 and any future unknown viral outbreak.|pdf=|us…“) |
|||
| Zeile 43: | Zeile 43: | ||
{{tp|p=32220035|t=2020. SARS-CoV-2: What do we know so far?|pdf=|usr=008}} | {{tp|p=32220035|t=2020. SARS-CoV-2: What do we know so far?|pdf=|usr=008}} | ||
{{tp|p=32534452|t=2020. From causes of aging to death from COVID-19.|pdf=|usr=008}} | {{tp|p=32534452|t=2020. From causes of aging to death from COVID-19.|pdf=|usr=008}} | ||
| − | + | ||
{{tp|p=32401346|t=2020. SARS-CoV-2 immunogenicity at the crossroads.|pdf=|usr=008}} | {{tp|p=32401346|t=2020. SARS-CoV-2 immunogenicity at the crossroads.|pdf=|usr=008}} | ||
{{tp|p=32516444|t=2020. Immunological environment shifts during pregnancy may affect the risk of developing severe complications in COVID-19 patients.|pdf=|usr=008}} | {{tp|p=32516444|t=2020. Immunological environment shifts during pregnancy may affect the risk of developing severe complications in COVID-19 patients.|pdf=|usr=008}} | ||
| Zeile 49: | Zeile 49: | ||
{{tp|p=32533824|t=2020. Tuberculosis and type 2 Diabetes Mellitus: an inflammatory danger signal in the time of COVID-19.|pdf=|usr=008}} | {{tp|p=32533824|t=2020. Tuberculosis and type 2 Diabetes Mellitus: an inflammatory danger signal in the time of COVID-19.|pdf=|usr=008}} | ||
{{tp|p=32425712|t=2020. Evidence Supporting a Phased Immuno-physiological Approach to COVID-19 From Prevention Through Recovery.|pdf=|usr=008}} | {{tp|p=32425712|t=2020. Evidence Supporting a Phased Immuno-physiological Approach to COVID-19 From Prevention Through Recovery.|pdf=|usr=008}} | ||
| + | |||
| + | |||
| + | |||
| + | {{tp|p=32541836|t=2020. Systemically comparing host immunity between survived and deceased COVID-19 patients.|pdf=|usr=010}} | ||
| + | {{tp|p=32574694|t=2020. Relationship between Chest CT manifestations and immune response in COVID-19 patients.|pdf=|usr=010}} | ||
| + | {{tp|p=32572247|t=2020. Sex differences in immune responses in COVID-19.|pdf=|usr=010}} | ||
| + | {{tp|p=32561873|t=2020. COVID-19 revisiting inflammatory pathways of arthritis.|pdf=|usr=010}} ##my mg index paper'' | ||
| + | {{tp|p=32589296|t=2020. COVID-19: A series of important recent clinical and laboratory reports in immunology and pathogenesis of SARS-CoV-2 infection and care of allergy patients.|pdf=|usr=010}} | ||
| + | {{tp|p=32579026|t=2020. COVID-19 Related Acute Respiratory Distress Syndrome: Not so Atypical.|pdf=|usr=010}} | ||
| + | {{ttp|p=32578486|t=2020. Autophagy/virophagy: a "disposal strategy" to combat COVID-19.|pdf=|usr=010}} | ||
| + | {{tp|p=32546768|t=2020. Immune status could determine efficacy of COVID-19 therapies.|pdf=|usr=010}} | ||
| + | {{tp|p=32555388|t=2020. Convergent antibody responses to SARS-CoV-2 in convalescent individuals.|pdf=|usr=010}} | ||
| + | {{tp|p=32603851|t=2020. Could the COVID-19 pandemic aggravate antimicrobial resistance?|pdf=|usr=011}} | ||
| + | {{tp|p=32537960|t=2020. A Pathophysiological Perspective on COVID-19's Lethal Complication: From Viremia to Hypersensitivity Pneumonitis-like Immune Dysregulation.|pdf=|usr=011}} | ||
| + | {{ttp|p=32587094|t=2020. SARS-CoV-2 (COVID-19) structural and evolutionary dynamicome: Insights into functional evolution and human genomics.|pdf=|usr=011}} | ||
| + | {{tp|p=32283140|t=2020. Re: Profile of specific antibodies to SARS-CoV-2: The first report.|pdf=|usr=011}} | ||
| + | {{tp|p=32540481|t=2020. Can the microcirculatory response to hypoxia be a prognostic factor for Covid-19?|pdf=|usr=011}} | ||
| + | {{ttp|p=32568186|t=2020. The compelling arguments for the need of microvascular investigation in COVID-19 critical patients.|pdf=|usr=011}} | ||
| + | {{tp|p=32602128|t=2020. Diarrhea and altered inflammatory cytokine pattern in severe COVID-19: impact on disease course and in-hospital mortality.|pdf=|usr=011}} | ||
| + | {{tp|p=32581799|t=2020. Molecular Insights Into SARS COV-2 Interaction With Cardiovascular Disease: Role of RAAS and MAPK Signaling.|pdf=|usr=011}} | ||
| + | {{tp|p=32605582|t=2020. Iron metabolism and lymphocyte characterisation during Covid-19 infection in ICU patients: an observational cohort study.|pdf=|usr=011}} | ||
| + | {{tp|p=32579244|t=2020. Clinical and biological data on the use of hydroxychloroquine against SARS-CoV-2 could support the role of the NLRP3 inflammasome in the pathogenesis of respiratory disease.|pdf=|usr=011}} | ||
| + | {{tp|p=32570166|t=2020. A hypothesis about the role of fetal hemoglobin in COVID-19.|pdf=|usr=011}} | ||
| + | {{ttp|p=32597823|t=2020. AhR and IDO1 in pathogenesis of Covid-19 and the "Systemic AhR Activation Syndrome:" Translational review and therapeutic perspectives.|pdf=|usr=011}} | ||
| + | {{tp|p=32520467|t=2020. COVID-19: A la recherche des anticorps protecteurs.|pdf=|usr=011}} | ||
| + | {{tp|p=32499416|t=2020. Sex hormones signal why virus hits men harder.|pdf=|usr=011}} | ||
Aktuelle Version vom 9. Juli 2020, 05:43 Uhr
32398026 2020. Allo-priming as a universal anti-viral vaccine: protecting elderly from current COVID-19 and any future unknown viral outbreak.
32522207 2020. COVID-19: viral-host interactome analyzed by network based-approach model to study pathogenesis of SARS-CoV-2 infection.
32446324 2020. Detection of SARS-CoV-2 in human breastmilk.
32460210 2020. "Therapeutic" facemasks.
32461674 2020. The non-specific and sex-differential effects of vaccines.
32409742 2020. SARS-CoV-2 likes it cool.
32533110 2020. SARS-CoV-2 has a sweet tooth.
32415242 2020. A spike with which to beat COVID-19?
32488173 2020. Antimicrobial use, drug-resistant infections and COVID-19.
32427206 2020. Rare and extreme events: the case of COVID-19 pandemic.
32412525 2020. The Myriad Ways in Which COVID-19 Revealed Character.
32528206 2020. COVID-19 and lessons learned from the pandemic wave of meningococcal meningitis (1985-1990).
32317245 2020. Ger Rijkers: Persistence of Memory in Times of COVID-19.
32417181 2020. COVID-19: CADD to the rescue.
32398780 2020. The role of the exposome in promoting resilience or susceptibility after SARS-CoV-2 infection.
32534002 2020. Cancer population may be paradoxically protected from severe manifestations of COVID-19.
| 32461703 2020. Mechanobiology predicts raft formations triggered by ligand-receptor activity across the cell membrane. |
32412125 2020. Androgen sensitivity gateway to COVID-19 disease severity.
32444797 2020. BBMRI-ERIC's contributions to research and knowledge exchange on COVID-19.
32415272 2020. Connecting data, tools and people across Europe: ELIXIR's response to the COVID-19 pandemic.
32376989 2020. The VODAN IN: support of a FAIR-based infrastructure for COVID-19.
32510005 2020. COVID-19 target: A specific target for novel coronavirus detection.
32437706 2020. Evolution of severe acute respiratory syndrome coronavirus 2 RNA test results in a patient with fatal coronavirus disease 2019: a case report.
32392464 2020. SARS-CoV-2: Combating Coronavirus Emergence.
32473952 2020. SARS-CoV-2: The viral shedding vs infectivity dilemma.
32405281 2020. Sars-CoV-2 and black population: ACE2 as shield or blade?
32524515 2020. Perceived versus proven SARS-CoV-2-specific immune responses in health-care professionals.
31896597 2020. Host AAA+ ATPase TER94 Plays Critical Roles in Building the Baculovirus Viral Replication Factory and Virion Morphogenesis.
32467367 2020. Scientists put survivors' blood plasma to the test.
32512133 2020. Poor-sleep is associated with slow recovery from lymphopenia and an increased need for ICU care in hospitalized patients with COVID-19: A retrospective cohort study.
32423901 2020. How covid-19 is accelerating the threat of antimicrobial resistance.
32504123 2020. COVID-19 research: toxicological input urgently needed!
32213337 ä. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study
32360743 ä. Lower detection rates of SARS-COV2 antibodies in cancer patients vs healthcare workers after symptomatic COVID-19
32292530 2020. Respiratory diseases, allergy and COVID-19 infection. First news from Wuhan
32346093 ä. The trinity of COVID-19: immunity, inflammation and intervention
32348636 2020. Hyposalivation as a potential risk for SARS-CoV-2 infection: Inhibitory role of saliva
32235915 ä. COVID-19: a new challenge for human beings
| 32359201 2020. The first, holistic immunological model of COVID-19: implications for prevention, diagnosis, and public health measures |
32376309 2020. Viral kinetics of SARS-CoV-2 in asymptomatic carriers and presymptomatic patients
32388390 2020. The powerful immune system against powerful COVID-19: A hypothesis
32372807 2020. The fever paradox
32220035 2020. SARS-CoV-2: What do we know so far?
32534452 2020. From causes of aging to death from COVID-19.
32401346 2020. SARS-CoV-2 immunogenicity at the crossroads.
32516444 2020. Immunological environment shifts during pregnancy may affect the risk of developing severe complications in COVID-19 patients.
32526483 2020. COVID 19 and brain crosstalks.
32533824 2020. Tuberculosis and type 2 Diabetes Mellitus: an inflammatory danger signal in the time of COVID-19.
32425712 2020. Evidence Supporting a Phased Immuno-physiological Approach to COVID-19 From Prevention Through Recovery.
32541836 2020. Systemically comparing host immunity between survived and deceased COVID-19 patients.
32574694 2020. Relationship between Chest CT manifestations and immune response in COVID-19 patients.
32572247 2020. Sex differences in immune responses in COVID-19.
32561873 2020. COVID-19 revisiting inflammatory pathways of arthritis. ##my mg index paper
32589296 2020. COVID-19: A series of important recent clinical and laboratory reports in immunology and pathogenesis of SARS-CoV-2 infection and care of allergy patients.
32579026 2020. COVID-19 Related Acute Respiratory Distress Syndrome: Not so Atypical.
| 32578486 2020. Autophagy/virophagy: a "disposal strategy" to combat COVID-19. |
32546768 2020. Immune status could determine efficacy of COVID-19 therapies.
32555388 2020. Convergent antibody responses to SARS-CoV-2 in convalescent individuals.
32603851 2020. Could the COVID-19 pandemic aggravate antimicrobial resistance?
32537960 2020. A Pathophysiological Perspective on COVID-19's Lethal Complication: From Viremia to Hypersensitivity Pneumonitis-like Immune Dysregulation.
| 32587094 2020. SARS-CoV-2 (COVID-19) structural and evolutionary dynamicome: Insights into functional evolution and human genomics. |
32283140 2020. Re: Profile of specific antibodies to SARS-CoV-2: The first report.
32540481 2020. Can the microcirculatory response to hypoxia be a prognostic factor for Covid-19?
| 32568186 2020. The compelling arguments for the need of microvascular investigation in COVID-19 critical patients. |
32602128 2020. Diarrhea and altered inflammatory cytokine pattern in severe COVID-19: impact on disease course and in-hospital mortality.
32581799 2020. Molecular Insights Into SARS COV-2 Interaction With Cardiovascular Disease: Role of RAAS and MAPK Signaling.
32605582 2020. Iron metabolism and lymphocyte characterisation during Covid-19 infection in ICU patients: an observational cohort study.
32579244 2020. Clinical and biological data on the use of hydroxychloroquine against SARS-CoV-2 could support the role of the NLRP3 inflammasome in the pathogenesis of respiratory disease.
32570166 2020. A hypothesis about the role of fetal hemoglobin in COVID-19.
| 32597823 2020. AhR and IDO1 in pathogenesis of Covid-19 and the "Systemic AhR Activation Syndrome:" Translational review and therapeutic perspectives. |
32520467 2020. COVID-19: A la recherche des anticorps protecteurs.
32499416 2020. Sex hormones signal why virus hits men harder.
